Alzheimer's disease drug development pipeline: 2023
Abstract Introduction Drugs that prevent the onset, slow progression, or improve cognitive and behavioral symptoms of Alzheimer's disease (AD) are needed. Methods We searched ClinicalTrials.gov for all current Phase 1, 2 and 3 clinical trials for AD and mild cognitive impairment (MCI) attributed to...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wiley
2023-04-01
|
| Col·lecció: | Alzheimer’s & Dementia: Translational Research & Clinical Interventions |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1002/trc2.12385 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|